Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duanpen Sandee

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Endocrinology|May 19, 2011
High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductaseDuanpen Sandee, Walter L Miller
Molecular Immunology|March 23, 2005
Construction of scFv derived from a tumor-associated monoclonal antibody having tumoricidal activity on human hepatocellular carcinomaSumalee Tungpradabkul, Duanpen Sandee, Songchan Puthong, et al.
BMC Biotechnology|September 14, 2002
Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinomaDuanpen Sandee, Sumalee Tungpradabkul, Manae Tsukio, et al.
Prostaglandins & Other Lipid Mediators|December 31, 2008
Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell linesDuanpen Sandee, Sasitorn Sivanuntakorn, Vanicha Vichai, et al.
Biotechnology and Bioengineering|June 7, 2005
Combination of Dsb coexpression and an addition of sorbitol markedly enhanced soluble expression of single-chain Fv in Escherichia coliDuanpen Sandee, Sumalee Tungpradabkul, Yoichi Kurokawa, et al.
Journal of Bioscience and Bioengineering|October 20, 2005
Tumor suppressive monoclonal antibody belonging to the V(H) 7183 family directed to the oncodevelopmental carbohydrate antigen on human hepatocellular carcinomaDuanpen Sandee, Sumalee Tungpradabkul, Kingkarn Laohathai, et al.
Pharmacogenetics and Genomics|May 2, 2012
Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3Murali Subramanian, Vishal Agrawal, Duanpen Sandee, et al.
Molecular and Cellular Endocrinology|November 13, 2010
Consequences of POR mutations and polymorphismsWalter L Miller, Vishal Agrawal, Duanpen Sandee, et al.
Pharmacogenetics and Genomics|October 14, 2010
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitroDuanpen Sandee, Kari Morrissey, Vishal Agrawal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Endocrinology|May 19, 2011
High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductaseDuanpen Sandee, Walter L Miller
Molecular Immunology|March 23, 2005
Construction of scFv derived from a tumor-associated monoclonal antibody having tumoricidal activity on human hepatocellular carcinomaSumalee Tungpradabkul, Duanpen Sandee, Songchan Puthong, et al.
BMC Biotechnology|September 14, 2002
Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinomaDuanpen Sandee, Sumalee Tungpradabkul, Manae Tsukio, et al.
Prostaglandins & Other Lipid Mediators|December 31, 2008
Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell linesDuanpen Sandee, Sasitorn Sivanuntakorn, Vanicha Vichai, et al.
Biotechnology and Bioengineering|June 7, 2005
Combination of Dsb coexpression and an addition of sorbitol markedly enhanced soluble expression of single-chain Fv in Escherichia coliDuanpen Sandee, Sumalee Tungpradabkul, Yoichi Kurokawa, et al.
Journal of Bioscience and Bioengineering|October 20, 2005
Tumor suppressive monoclonal antibody belonging to the V(H) 7183 family directed to the oncodevelopmental carbohydrate antigen on human hepatocellular carcinomaDuanpen Sandee, Sumalee Tungpradabkul, Kingkarn Laohathai, et al.
Pharmacogenetics and Genomics|May 2, 2012
Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3Murali Subramanian, Vishal Agrawal, Duanpen Sandee, et al.
Molecular and Cellular Endocrinology|November 13, 2010
Consequences of POR mutations and polymorphismsWalter L Miller, Vishal Agrawal, Duanpen Sandee, et al.
Pharmacogenetics and Genomics|October 14, 2010
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitroDuanpen Sandee, Kari Morrissey, Vishal Agrawal, et al.
Pageof 1